

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.90393572 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.71491366 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.51576017 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.51576017 |
| 5 | exogenous drug catabolic process (GO:0042738) | 7.38632069 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.18487770 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18487770 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.69791680 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.18857355 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.98167129 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.98167129 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.98167129 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.86360191 |
| 14 | oxidative demethylation (GO:0070989) | 5.84427936 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.78461134 |
| 16 | tryptophan metabolic process (GO:0006568) | 5.65068602 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63164839 |
| 18 | regulation of plasminogen activation (GO:0010755) | 5.62968791 |
| 19 | drug metabolic process (GO:0017144) | 5.62404703 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.57902714 |
| 21 | urea cycle (GO:0000050) | 5.57870263 |
| 22 | urea metabolic process (GO:0019627) | 5.57870263 |
| 23 | phenylpropanoid metabolic process (GO:0009698) | 5.50885182 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.45044650 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 5.40116416 |
| 26 | ethanol metabolic process (GO:0006067) | 5.39838650 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.33154139 |
| 28 | protein carboxylation (GO:0018214) | 5.28168275 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.28168275 |
| 30 | cysteine metabolic process (GO:0006534) | 5.27735654 |
| 31 | complement activation, alternative pathway (GO:0006957) | 5.23857504 |
| 32 | regulation of fibrinolysis (GO:0051917) | 5.22876926 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.13392895 |
| 34 | regulation of protein activation cascade (GO:2000257) | 5.11915670 |
| 35 | acute-phase response (GO:0006953) | 5.10850051 |
| 36 | opsonization (GO:0008228) | 5.05289674 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 5.02874350 |
| 38 | bile acid metabolic process (GO:0008206) | 5.00431221 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.86992864 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.84207582 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.84207582 |
| 42 | regulation of complement activation (GO:0030449) | 4.78836094 |
| 43 | regulation of humoral immune response (GO:0002920) | 4.76749588 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.75272474 |
| 45 | reverse cholesterol transport (GO:0043691) | 4.75241666 |
| 46 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74789749 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.74458732 |
| 48 | regulation of cholesterol esterification (GO:0010872) | 4.71661997 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.66397068 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.65270778 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.65270778 |
| 52 | plasma lipoprotein particle remodeling (GO:0034369) | 4.65270778 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.64855776 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.64855776 |
| 55 | lysine catabolic process (GO:0006554) | 4.58615365 |
| 56 | lysine metabolic process (GO:0006553) | 4.58615365 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.57717190 |
| 58 | alkaloid metabolic process (GO:0009820) | 4.54163730 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.47997682 |
| 60 | negative regulation of protein activation cascade (GO:2000258) | 4.46862021 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.44994659 |
| 62 | phospholipid efflux (GO:0033700) | 4.41760926 |
| 63 | negative regulation of sterol transport (GO:0032372) | 4.41467559 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 4.41467559 |
| 65 | negative regulation of coagulation (GO:0050819) | 4.39971391 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.39419354 |
| 67 | negative regulation of wound healing (GO:0061045) | 4.38447727 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.37800349 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.32378706 |
| 70 | bile acid and bile salt transport (GO:0015721) | 4.30395344 |
| 71 | glycine metabolic process (GO:0006544) | 4.27535402 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 4.27282973 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.23687091 |
| 74 | glutamate metabolic process (GO:0006536) | 4.13559007 |
| 75 | amine catabolic process (GO:0009310) | 4.12424021 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.12424021 |
| 77 | cellular glucuronidation (GO:0052695) | 4.10099348 |
| 78 | positive regulation of blood coagulation (GO:0030194) | 4.09803369 |
| 79 | positive regulation of hemostasis (GO:1900048) | 4.09803369 |
| 80 | cholesterol efflux (GO:0033344) | 4.07954968 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.05289934 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 4.01164711 |
| 83 | ethanol oxidation (GO:0006069) | 4.00643421 |
| 84 | S-adenosylmethionine metabolic process (GO:0046500) | 4.00027561 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.98963492 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.89838243 |
| 87 | arginine metabolic process (GO:0006525) | 3.89277349 |
| 88 | acute inflammatory response (GO:0002526) | 3.88214070 |
| 89 | plasma lipoprotein particle assembly (GO:0034377) | 3.86511335 |
| 90 | negative regulation of complement activation (GO:0045916) | 3.86101888 |
| 91 | ketone body metabolic process (GO:1902224) | 3.84885305 |
| 92 | fibrinolysis (GO:0042730) | 3.84124520 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82071498 |
| 94 | drug catabolic process (GO:0042737) | 3.81503310 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.81272355 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.78449538 |
| 97 | positive regulation of coagulation (GO:0050820) | 3.78162571 |
| 98 | acetyl-CoA metabolic process (GO:0006084) | 3.76102283 |
| 99 | short-chain fatty acid metabolic process (GO:0046459) | 3.73769597 |
| 100 | organic acid catabolic process (GO:0016054) | 3.73623302 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.73623302 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.72883922 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.72883922 |
| 104 | steroid catabolic process (GO:0006706) | 3.72463072 |
| 105 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.72250602 |
| 106 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.72250602 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.70801051 |
| 108 | regulation of lipoprotein particle clearance (GO:0010984) | 3.70277431 |
| 109 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69465525 |
| 110 | phospholipid homeostasis (GO:0055091) | 3.68929263 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.68197059 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67996777 |
| 113 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.67906475 |
| 114 | cofactor catabolic process (GO:0051187) | 3.67736984 |
| 115 | negative regulation of lipase activity (GO:0060192) | 3.67630208 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.63793741 |
| 117 | complement activation, classical pathway (GO:0006958) | 3.63763278 |
| 118 | glucuronate metabolic process (GO:0019585) | 3.63330434 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.63330434 |
| 120 | sterol homeostasis (GO:0055092) | 3.62543466 |
| 121 | complement activation (GO:0006956) | 3.61873365 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58628449 |
| 123 | protein activation cascade (GO:0072376) | 3.58599890 |
| 124 | peptidyl-glutamic acid modification (GO:0018200) | 3.58380566 |
| 125 | cytolysis (GO:0019835) | 3.55198630 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.53278791 |
| 127 | monocarboxylic acid catabolic process (GO:0072329) | 3.46805113 |
| 128 | protein-lipid complex assembly (GO:0065005) | 3.46221242 |
| 129 | 2-oxoglutarate metabolic process (GO:0006103) | 3.46026321 |
| 130 | heme transport (GO:0015886) | 3.45158391 |
| 131 | proline metabolic process (GO:0006560) | 3.44550960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.29251125 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.11504724 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.82423913 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47323950 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.25616523 |
| 6 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.04198992 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00396770 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01052968 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80407428 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15652342 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02831806 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6717013 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97503278 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72107340 |
| 15 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61539228 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.52372088 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50927861 |
| 18 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43897126 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40136053 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39971998 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36838781 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.29916406 |
| 23 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21851999 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17567776 |
| 25 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16158502 |
| 26 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14264416 |
| 27 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.13516381 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03863909 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03755272 |
| 30 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02505719 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02368068 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.02080522 |
| 33 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00113254 |
| 34 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99809534 |
| 35 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98647550 |
| 36 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96464622 |
| 37 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.95414653 |
| 38 | P68_20966046_ChIP-Seq_HELA_Human | 0.94842123 |
| 39 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.94816379 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91847809 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91418395 |
| 42 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.91209791 |
| 43 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91120458 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90611685 |
| 45 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90538382 |
| 46 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90435839 |
| 47 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.90044848 |
| 48 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89961652 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89822052 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89281553 |
| 51 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88201619 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86794659 |
| 53 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.85642854 |
| 54 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.84202206 |
| 55 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.83307000 |
| 56 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83038363 |
| 57 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.82893443 |
| 58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.81954023 |
| 59 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81541795 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81313668 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81292811 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81157984 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80733039 |
| 64 | P300_27268052_Chip-Seq_Bcells_Human | 0.79522652 |
| 65 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79305970 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78317052 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78107292 |
| 68 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77682937 |
| 69 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76120824 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75478961 |
| 71 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.75369409 |
| 72 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74569025 |
| 73 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.74302652 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74289440 |
| 75 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.73913932 |
| 76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73192565 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69117424 |
| 78 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69013775 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68171811 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.68157711 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.67865223 |
| 82 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.67307953 |
| 83 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.67237670 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67115329 |
| 85 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.66997331 |
| 86 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.65741541 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65400128 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64771858 |
| 89 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64624520 |
| 90 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64624520 |
| 91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64461820 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63709458 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 0.63557803 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.63520942 |
| 95 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63482351 |
| 96 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63267782 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62137800 |
| 98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62075182 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.61814528 |
| 100 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.61252031 |
| 101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61008502 |
| 102 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.60528081 |
| 103 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.60504154 |
| 104 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.60288208 |
| 105 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.60079851 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.59999195 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58988554 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57742546 |
| 109 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56941312 |
| 110 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55250731 |
| 111 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55206967 |
| 112 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52737464 |
| 113 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52056224 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51358765 |
| 115 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51085067 |
| 116 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50733423 |
| 117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50687070 |
| 118 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50394676 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49267489 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.49228506 |
| 121 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.48948454 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48534239 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48432584 |
| 124 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47937609 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.45092068 |
| 126 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44102080 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.43654531 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43523318 |
| 129 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43090784 |
| 130 | * ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.43000724 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42878997 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42230276 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.41776877 |
| 134 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40889723 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.40805516 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40687159 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.40619720 |
| 138 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40567263 |
| 139 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.39735662 |
| 140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39683673 |
| 141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39630227 |
| 142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39359734 |
| 143 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39068390 |
| 144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38844245 |
| 145 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37308565 |
| 146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.37306700 |
| 147 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36896598 |
| 148 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36760724 |
| 149 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36747038 |
| 150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36242570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.19295641 |
| 2 | MP0005360_urolithiasis | 7.41671866 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.30499050 |
| 4 | MP0005365_abnormal_bile_salt | 6.10704286 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.97345197 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.15307008 |
| 7 | MP0003252_abnormal_bile_duct | 3.78703545 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61029908 |
| 9 | MP0009840_abnormal_foam_cell | 3.17060061 |
| 10 | MP0005083_abnormal_biliary_tract | 3.16134033 |
| 11 | MP0003195_calcinosis | 3.04212416 |
| 12 | MP0005332_abnormal_amino_acid | 2.76924100 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.63526053 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.26871177 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.19499232 |
| 16 | MP0000609_abnormal_liver_physiology | 2.18002546 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.17718324 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.97074885 |
| 19 | MP0003868_abnormal_feces_composition | 1.96186508 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82039273 |
| 21 | MP0001764_abnormal_homeostasis | 1.72195591 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.55536004 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53870643 |
| 24 | MP0009697_abnormal_copulation | 1.46818593 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.34781988 |
| 26 | MP0005451_abnormal_body_composition | 1.32878872 |
| 27 | MP0003011_delayed_dark_adaptation | 1.29418003 |
| 28 | MP0002254_reproductive_system_inflammat | 1.28860159 |
| 29 | MP0003186_abnormal_redox_activity | 1.25750684 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.20210959 |
| 31 | MP0005647_abnormal_sex_gland | 1.15991725 |
| 32 | MP0000598_abnormal_liver_morphology | 1.15769571 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.11666612 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.11438877 |
| 35 | MP0005670_abnormal_white_adipose | 1.01416570 |
| 36 | MP0002132_abnormal_respiratory_system | 1.00923007 |
| 37 | MP0000604_amyloidosis | 0.99985042 |
| 38 | MP0009763_increased_sensitivity_to | 0.97738691 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.96875275 |
| 40 | MP0009764_decreased_sensitivity_to | 0.95731612 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 0.95729654 |
| 42 | MP0003879_abnormal_hair_cell | 0.93380105 |
| 43 | MP0005220_abnormal_exocrine_pancreas | 0.91601479 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.88679970 |
| 45 | MP0004130_abnormal_muscle_cell | 0.86786291 |
| 46 | MP0010368_abnormal_lymphatic_system | 0.86082509 |
| 47 | MP0008469_abnormal_protein_level | 0.85782028 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.84626472 |
| 49 | MP0002971_abnormal_brown_adipose | 0.83902358 |
| 50 | MP0002282_abnormal_trachea_morphology | 0.83255426 |
| 51 | MP0005408_hypopigmentation | 0.81997215 |
| 52 | MP0005334_abnormal_fat_pad | 0.81160472 |
| 53 | MP0005376_homeostasis/metabolism_phenot | 0.78136049 |
| 54 | MP0005535_abnormal_body_temperature | 0.77857695 |
| 55 | MP0002249_abnormal_larynx_morphology | 0.75789843 |
| 56 | MP0001661_extended_life_span | 0.75478018 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 0.74104024 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.73663471 |
| 59 | MP0001881_abnormal_mammary_gland | 0.71039291 |
| 60 | MP0001756_abnormal_urination | 0.69327642 |
| 61 | MP0005448_abnormal_energy_balance | 0.66367900 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 0.64269461 |
| 63 | MP0003690_abnormal_glial_cell | 0.63930325 |
| 64 | MP0005266_abnormal_metabolism | 0.63137106 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.62886842 |
| 66 | MP0003329_amyloid_beta_deposits | 0.57164090 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.57145039 |
| 68 | MP0005187_abnormal_penis_morphology | 0.55394150 |
| 69 | MP0009053_abnormal_anal_canal | 0.53931454 |
| 70 | MP0002928_abnormal_bile_duct | 0.51966279 |
| 71 | MP0005395_other_phenotype | 0.51545324 |
| 72 | MP0003953_abnormal_hormone_level | 0.51384575 |
| 73 | MP0001915_intracranial_hemorrhage | 0.50684454 |
| 74 | MP0000003_abnormal_adipose_tissue | 0.48488871 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.47298572 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.47001356 |
| 77 | MP0010386_abnormal_urinary_bladder | 0.46682629 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 0.46586780 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.46307476 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.44915604 |
| 81 | MP0009785_altered_susceptibility_to | 0.44785702 |
| 82 | MP0003718_maternal_effect | 0.44585306 |
| 83 | MP0002970_abnormal_white_adipose | 0.43592379 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.42901293 |
| 85 | MP0009672_abnormal_birth_weight | 0.42091482 |
| 86 | MP0009115_abnormal_fat_cell | 0.42005329 |
| 87 | MP0001944_abnormal_pancreas_morphology | 0.41670286 |
| 88 | MP0008874_decreased_physiological_sensi | 0.40683058 |
| 89 | MP0003724_increased_susceptibility_to | 0.38681373 |
| 90 | MP0008873_increased_physiological_sensi | 0.38591647 |
| 91 | MP0002168_other_aberrant_phenotype | 0.38276189 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 0.38221648 |
| 93 | MP0000579_abnormal_nail_morphology | 0.38147367 |
| 94 | MP0003075_altered_response_to | 0.38092890 |
| 95 | MP0005248_abnormal_Harderian_gland | 0.37571796 |
| 96 | MP0002796_impaired_skin_barrier | 0.37336483 |
| 97 | MP0004043_abnormal_pH_regulation | 0.36962649 |
| 98 | MP0002822_catalepsy | 0.36902710 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.36098977 |
| 100 | MP0003436_decreased_susceptibility_to | 0.35980714 |
| 101 | MP0003959_abnormal_lean_body | 0.35678638 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.32656314 |
| 103 | MP0005646_abnormal_pituitary_gland | 0.32324995 |
| 104 | MP0000371_diluted_coat_color | 0.31865872 |
| 105 | MP0008872_abnormal_physiological_respon | 0.30350406 |
| 106 | MP0000249_abnormal_blood_vessel | 0.30292054 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.29472436 |
| 108 | MP0001243_abnormal_dermal_layer | 0.29449771 |
| 109 | MP0006082_CNS_inflammation | 0.29411494 |
| 110 | MP0005166_decreased_susceptibility_to | 0.28707570 |
| 111 | MP0002060_abnormal_skin_morphology | 0.28542846 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.28146734 |
| 113 | MP0004381_abnormal_hair_follicle | 0.28082898 |
| 114 | MP0000678_abnormal_parathyroid_gland | 0.28013080 |
| 115 | MP0002089_abnormal_postnatal_growth/wei | 0.27844192 |
| 116 | MP0000467_abnormal_esophagus_morphology | 0.25748329 |
| 117 | MP0005410_abnormal_fertilization | 0.25648458 |
| 118 | MP0002736_abnormal_nociception_after | 0.24766195 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.24085414 |
| 120 | MP0005023_abnormal_wound_healing | 0.23873564 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.23763068 |
| 122 | MP0001968_abnormal_touch/_nociception | 0.22797084 |
| 123 | MP0001845_abnormal_inflammatory_respons | 0.22153772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42043360 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.21224861 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.16701212 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47854443 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.43978496 |
| 6 | Xanthomatosis (HP:0000991) | 6.16867890 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.16849445 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.49554671 |
| 9 | Complement deficiency (HP:0004431) | 5.20120584 |
| 10 | Joint hemorrhage (HP:0005261) | 4.68840348 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.66449704 |
| 12 | Hyperammonemia (HP:0001987) | 4.54561025 |
| 13 | Ketosis (HP:0001946) | 4.48541913 |
| 14 | Hyperglycinemia (HP:0002154) | 4.47573841 |
| 15 | Epidermoid cyst (HP:0200040) | 4.46542302 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.37880399 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.28966841 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.20991493 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.15619888 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.12359737 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12140827 |
| 22 | Hyperglycinuria (HP:0003108) | 4.12106109 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.11664368 |
| 24 | Fat malabsorption (HP:0002630) | 4.06677883 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02217131 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 4.02217131 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00103221 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.96114004 |
| 29 | Abnormality of complement system (HP:0005339) | 3.77919950 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66772643 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.62584366 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.55642611 |
| 33 | Nephritis (HP:0000123) | 3.50412650 |
| 34 | Ketoacidosis (HP:0001993) | 3.46001811 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.42271870 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.38795614 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.27161058 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.16275090 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.05413114 |
| 40 | Steatorrhea (HP:0002570) | 3.05310187 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.03269232 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.93469503 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 2.93120452 |
| 44 | Myocardial infarction (HP:0001658) | 2.91684452 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.86857801 |
| 46 | Skin nodule (HP:0200036) | 2.84371386 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.82692079 |
| 48 | Metabolic acidosis (HP:0001942) | 2.76963357 |
| 49 | Fair hair (HP:0002286) | 2.76063112 |
| 50 | Gout (HP:0001997) | 2.71319152 |
| 51 | Spontaneous abortion (HP:0005268) | 2.69614989 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.65410923 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.65410923 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.63975183 |
| 55 | Lethargy (HP:0001254) | 2.60951122 |
| 56 | Vascular calcification (HP:0004934) | 2.53480693 |
| 57 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.49678456 |
| 58 | Purpura (HP:0000979) | 2.49642810 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.47645227 |
| 60 | Irritability (HP:0000737) | 2.42957256 |
| 61 | Osteomalacia (HP:0002749) | 2.39697432 |
| 62 | Acanthocytosis (HP:0001927) | 2.38812258 |
| 63 | Cholelithiasis (HP:0001081) | 2.37309475 |
| 64 | Mitral stenosis (HP:0001718) | 2.37103128 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.37032968 |
| 66 | Late onset (HP:0003584) | 2.36547120 |
| 67 | Cerebral edema (HP:0002181) | 2.35933579 |
| 68 | Glomerulonephritis (HP:0000099) | 2.35616365 |
| 69 | Spastic diplegia (HP:0001264) | 2.32086453 |
| 70 | Neonatal hypoglycemia (HP:0001998) | 2.31015795 |
| 71 | Pulmonary embolism (HP:0002204) | 2.28479323 |
| 72 | Neonatal onset (HP:0003623) | 2.27353434 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.25352700 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.24913364 |
| 75 | Pancreatitis (HP:0001733) | 2.21660872 |
| 76 | Malnutrition (HP:0004395) | 2.18657007 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17349150 |
| 78 | Brushfield spots (HP:0001088) | 2.16898903 |
| 79 | Esophageal varix (HP:0002040) | 2.16310085 |
| 80 | Amyloidosis (HP:0011034) | 2.15668807 |
| 81 | Cholecystitis (HP:0001082) | 2.14685773 |
| 82 | Abnormal gallbladder physiology (HP:0012438) | 2.14685773 |
| 83 | Enlarged kidneys (HP:0000105) | 2.13663673 |
| 84 | Hyperglycemia (HP:0003074) | 2.13210399 |
| 85 | Menorrhagia (HP:0000132) | 2.11868773 |
| 86 | Atrioventricular block (HP:0001678) | 2.11631146 |
| 87 | Vomiting (HP:0002013) | 2.08173110 |
| 88 | Opisthotonus (HP:0002179) | 2.07493622 |
| 89 | Sensorimotor neuropathy (HP:0007141) | 2.04570580 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.03530253 |
| 91 | Gingival bleeding (HP:0000225) | 2.02887708 |
| 92 | Symptomatic seizures (HP:0011145) | 2.02564680 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 1.99247943 |
| 94 | Hydroxyprolinuria (HP:0003080) | 1.99247943 |
| 95 | Generalized hypopigmentation of hair (HP:0011358) | 1.98914011 |
| 96 | Abnormality of the gallbladder (HP:0005264) | 1.98704944 |
| 97 | Increased serum ferritin (HP:0003281) | 1.98340826 |
| 98 | Epistaxis (HP:0000421) | 1.98233087 |
| 99 | Thrombophlebitis (HP:0004418) | 1.93968403 |
| 100 | Rickets (HP:0002748) | 1.93361029 |
| 101 | Genetic anticipation (HP:0003743) | 1.89340896 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89325328 |
| 103 | Hyperphosphaturia (HP:0003109) | 1.88909776 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88630641 |
| 105 | Poikilocytosis (HP:0004447) | 1.87995978 |
| 106 | Elevated alkaline phosphatase (HP:0003155) | 1.87594234 |
| 107 | Hypochromic anemia (HP:0001931) | 1.87042934 |
| 108 | Abnormal cartilage morphology (HP:0002763) | 1.86796665 |
| 109 | Alkalosis (HP:0001948) | 1.86716388 |
| 110 | Renal cortical cysts (HP:0000803) | 1.84053931 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.83970566 |
| 112 | Dysmetric saccades (HP:0000641) | 1.82535528 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.82472323 |
| 114 | Gangrene (HP:0100758) | 1.81984871 |
| 115 | Hyperuricemia (HP:0002149) | 1.81466503 |
| 116 | Increased purine levels (HP:0004368) | 1.81466503 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.81063914 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77934211 |
| 119 | Mucopolysacchariduria (HP:0008155) | 1.77934211 |
| 120 | Hypophosphatemic rickets (HP:0004912) | 1.77831084 |
| 121 | Arthropathy (HP:0003040) | 1.76700104 |
| 122 | Glycosuria (HP:0003076) | 1.76103504 |
| 123 | Abnormality of urine glucose concentration (HP:0011016) | 1.76103504 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.73803259 |
| 125 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71945931 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68745370 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68745370 |
| 128 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68745370 |
| 129 | Blue irides (HP:0000635) | 1.65542082 |
| 130 | Abnormality of the hepatic vasculature (HP:0006707) | 1.64912012 |
| 131 | Hypophosphatemia (HP:0002148) | 1.60890905 |
| 132 | Cerebral palsy (HP:0100021) | 1.53131186 |
| 133 | Abnormal biliary tract physiology (HP:0012439) | 1.52640505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.94795563 |
| 2 | CDK19 | 4.97208730 |
| 3 | SIK1 | 4.84066765 |
| 4 | ERN1 | 4.36156603 |
| 5 | FGFR4 | 4.33806782 |
| 6 | INSRR | 3.86206392 |
| 7 | TNK2 | 3.07786636 |
| 8 | TAOK3 | 3.02560282 |
| 9 | OXSR1 | 2.89793819 |
| 10 | ERBB4 | 2.56388001 |
| 11 | PKN2 | 2.35294669 |
| 12 | TRIB3 | 2.32968221 |
| 13 | FLT3 | 2.05965499 |
| 14 | MST1R | 1.91367925 |
| 15 | MAP2K4 | 1.90327635 |
| 16 | PIK3CG | 1.84259339 |
| 17 | NTRK3 | 1.74683951 |
| 18 | MAPK11 | 1.71365322 |
| 19 | FRK | 1.70193029 |
| 20 | PTK6 | 1.66303531 |
| 21 | LATS1 | 1.60442089 |
| 22 | TYK2 | 1.53083477 |
| 23 | DAPK2 | 1.48851350 |
| 24 | PRPF4B | 1.45533918 |
| 25 | BLK | 1.45392000 |
| 26 | MAPK15 | 1.44038643 |
| 27 | MUSK | 1.36716479 |
| 28 | CAMK1D | 1.30453931 |
| 29 | PRKAA2 | 1.25545010 |
| 30 | JAK2 | 1.24459388 |
| 31 | NEK9 | 1.20639139 |
| 32 | ABL2 | 1.15656129 |
| 33 | FGFR2 | 1.13506905 |
| 34 | EPHA3 | 1.13100666 |
| 35 | STK38L | 1.07722230 |
| 36 | MAP3K7 | 1.07377183 |
| 37 | KDR | 1.06909425 |
| 38 | PINK1 | 1.06297535 |
| 39 | WNK4 | 1.05582319 |
| 40 | JAK1 | 1.00553791 |
| 41 | MET | 0.97095662 |
| 42 | TBK1 | 0.96864236 |
| 43 | EPHB1 | 0.96525410 |
| 44 | DYRK1B | 0.93474600 |
| 45 | IRAK3 | 0.92190723 |
| 46 | MAP3K14 | 0.91546945 |
| 47 | MAP3K10 | 0.91423790 |
| 48 | MAP3K3 | 0.88497497 |
| 49 | CAMKK1 | 0.83744477 |
| 50 | ERBB2 | 0.83341439 |
| 51 | MAP2K3 | 0.83322271 |
| 52 | ADRBK2 | 0.81962302 |
| 53 | RIPK1 | 0.80084901 |
| 54 | PRKCZ | 0.79662129 |
| 55 | GRK6 | 0.78688254 |
| 56 | TIE1 | 0.78089668 |
| 57 | PRKAA1 | 0.77791958 |
| 58 | SIK2 | 0.76845456 |
| 59 | MAPK4 | 0.75250782 |
| 60 | PTK2 | 0.72610825 |
| 61 | PRKACG | 0.72517857 |
| 62 | STK11 | 0.71707614 |
| 63 | CSNK1D | 0.70436898 |
| 64 | SMG1 | 0.70265940 |
| 65 | TLK1 | 0.69899177 |
| 66 | PRKG1 | 0.69794639 |
| 67 | GSK3A | 0.69680218 |
| 68 | HIPK2 | 0.69404256 |
| 69 | CAMK1G | 0.69145590 |
| 70 | FGFR3 | 0.67411514 |
| 71 | CDK6 | 0.66510848 |
| 72 | PRKACA | 0.65689292 |
| 73 | STK38 | 0.63643734 |
| 74 | CSK | 0.62687461 |
| 75 | MAPK12 | 0.62374110 |
| 76 | TGFBR2 | 0.58662065 |
| 77 | TXK | 0.57011325 |
| 78 | CAMK2G | 0.56141764 |
| 79 | RET | 0.54918017 |
| 80 | SGK3 | 0.52285545 |
| 81 | PDPK1 | 0.51425381 |
| 82 | MAP2K6 | 0.50794141 |
| 83 | IRAK1 | 0.50201270 |
| 84 | MAP3K11 | 0.50190166 |
| 85 | PDK4 | 0.48970099 |
| 86 | PDK3 | 0.48970099 |
| 87 | ACVR1B | 0.46936125 |
| 88 | IGF1R | 0.46297375 |
| 89 | MAPK7 | 0.45214492 |
| 90 | IKBKE | 0.44326833 |
| 91 | MTOR | 0.44182739 |
| 92 | MAP3K2 | 0.43766345 |
| 93 | MAP4K1 | 0.41999237 |
| 94 | MAP3K1 | 0.40920732 |
| 95 | BMX | 0.39997379 |
| 96 | MAPK3 | 0.39497867 |
| 97 | MAP2K1 | 0.39178166 |
| 98 | GRK1 | 0.38956270 |
| 99 | PRKCQ | 0.38896615 |
| 100 | SGK2 | 0.38048999 |
| 101 | EPHA2 | 0.37989013 |
| 102 | RPS6KA3 | 0.37935071 |
| 103 | CSF1R | 0.37809617 |
| 104 | SGK1 | 0.37652799 |
| 105 | MARK2 | 0.35827993 |
| 106 | PDK2 | 0.35444681 |
| 107 | PDGFRA | 0.35026260 |
| 108 | PIK3CA | 0.34266303 |
| 109 | MAP2K2 | 0.33944707 |
| 110 | CSNK1G1 | 0.33941949 |
| 111 | CAMKK2 | 0.31382472 |
| 112 | SRC | 0.31061945 |
| 113 | IKBKB | 0.30998650 |
| 114 | SGK494 | 0.30843867 |
| 115 | SGK223 | 0.30843867 |
| 116 | MAP3K6 | 0.30532611 |
| 117 | PDK1 | 0.29866508 |
| 118 | EPHA4 | 0.29747756 |
| 119 | MAPKAPK3 | 0.29430483 |
| 120 | BMPR1B | 0.28976627 |
| 121 | KSR2 | 0.28479144 |
| 122 | CDK4 | 0.28248066 |
| 123 | PRKCG | 0.28121956 |
| 124 | EGFR | 0.27986077 |
| 125 | ICK | 0.27186566 |
| 126 | MAP3K5 | 0.26115334 |
| 127 | AKT3 | 0.26002348 |
| 128 | PKN1 | 0.25948924 |
| 129 | TAOK2 | 0.25519829 |
| 130 | CHUK | 0.25449495 |
| 131 | FER | 0.23761311 |
| 132 | CAMK4 | 0.23663913 |
| 133 | ZAP70 | 0.23531978 |
| 134 | IRAK2 | 0.23465725 |
| 135 | PRKCA | 0.22554863 |
| 136 | MAP3K13 | 0.21939035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40008811 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.47256084 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29844289 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26781539 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98800454 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69595547 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66613585 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65686339 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63064737 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50022122 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46952968 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46821288 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22182346 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17474133 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09017066 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07770473 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00927252 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94735681 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91569881 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91013701 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89308862 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88781886 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86942341 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86889764 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77908311 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70838519 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.69406978 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68340185 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65766477 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64195916 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60222651 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.60128120 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57562207 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52921014 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49744720 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49398999 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.45996737 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45285723 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41741802 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.41411091 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.31823946 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28907627 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27966383 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22772514 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22604021 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.20648964 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.17565356 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16109067 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11932044 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04075352 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03553155 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95746425 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94628181 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92164837 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87378352 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86093558 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83205536 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.81889250 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79072878 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78353892 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74530378 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69865087 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69127485 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60140726 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59794177 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55379594 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46344766 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.40434890 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39328488 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37968013 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.34650232 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31615870 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.31116096 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29045053 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27955917 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26859936 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18146764 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17431274 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15754675 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14404477 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08986293 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.03028775 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.00227036 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00159677 |
| 85 | Lysosome_Homo sapiens_hsa04142 | -0.2094243 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1970879 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1965793 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1937377 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1923810 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1798025 |
| 91 | Hepatitis C_Homo sapiens_hsa05160 | -0.1772964 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1764595 |
| 93 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1574529 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1544501 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1542771 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1528043 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1458045 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1441346 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1354402 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1035570 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.1020126 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0944616 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0725998 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0646493 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0636001 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0483874 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0385995 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0338646 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0334641 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0225394 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0198040 |

